Mandate

Vinge advises J.P. Morgan on connection with SAS’s SEK 1.60 billion convertible bonds issue

March 22, 2010

Vinge has advised J.P. Morgan Securities Ltd (”J.P. Morgan”) with respect to Swedish law matters in connection with SAS AB’s (publ) SEK 1.60 billion directed issue of convertible bonds. J.P. Morgan is acting as sole bookrunner with respect to the issue. The bonds have been marketed principally to European institutional investors who have specialized knowledge of such instruments. Assuming that various conditions are met, among others that SAS’s annual general meeting authorizes the board of directors to resolve on an issue of convertibles and that the annual general meeting approves the previously announced rights issue, the bonds may be converted into ordinary shares.

Vinge’s team consisted of Rikard Stenberg, Johan Thiman and Mattias Schömer.

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024